These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9613986)

  • 21. Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.
    M'kacher R; Bennaceur-Griscelli A; Girinsky T; Koscielny S; Delhommeau F; Dossou J; Violot D; Leclercq E; Courtier MH; Béron-Gaillard N; Assaf E; Ribrag V; Bourhis J; Feneux D; Bernheim A; Parmentier C; Carde P
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):465-71. PubMed ID: 17418962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease.
    Nichols KE; Levitz S; Shannon KE; Wahrer DC; Bell DW; Chang G; Hegde S; Neuberg D; Shafman T; Tarbell NJ; Mauch P; Ishioka C; Haber DA; Diller L
    J Clin Oncol; 1999 Apr; 17(4):1259. PubMed ID: 10561187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetic effects of etoposide (VP-16) on human lymphocytes; with special reference to the relation between sister chromatid exchange and chromatid breakage.
    Tominaga K; Shinkai T; Saijo N; Nakajima T; Ochi H; Suemasu K
    Jpn J Cancer Res; 1986 Apr; 77(4):385-91. PubMed ID: 3084428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sister chromatid exchanges and chromosomes in chronic myelogenous leukemia and cancer families.
    Cheng WS; Mulvihill JJ; Greene MH; Pickle LW; Tsai S; Whang-Peng J
    Int J Cancer; 1979 Jan; 23(1):8-13. PubMed ID: 282271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.
    Dores GM; Metayer C; Curtis RE; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; van Leeuwen FE; Holowaty EJ; Andersson M; Wiklund T; Joensuu T; van't Veer MB; Stovall M; Gospodarowicz M; Travis LB
    J Clin Oncol; 2002 Aug; 20(16):3484-94. PubMed ID: 12177110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of breast cancer after Hodgkin's disease.
    Wolden SL; Hancock SL; Carlson RW; Goffinet DR; Jeffrey SS; Hoppe RT
    J Clin Oncol; 2000 Feb; 18(4):765-72. PubMed ID: 10673517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
    Lichtman SM; Brody J; Kaplan MH; Susin M; Koduru P; Goh JC
    Leuk Lymphoma; 1993 Mar; 9(4-5):393-8. PubMed ID: 7688628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
    Jaffe ES; Zarate-Osorno A; Medeiros LJ
    Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms.
    Nichols KE; Heath JA; Friedman D; Biegel JA; Ganguly A; Mauch P; Diller L
    J Clin Oncol; 2003 Dec; 21(24):4505-9. PubMed ID: 14673037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic susceptibility to Hodgkin's lymphoma and to secondary cancer: workshop report.
    Staratschek-Jox A; Shugart YY; Strom SS; Nagler A; Taylor GM
    Ann Oncol; 2002; 13 Suppl 1():30-3. PubMed ID: 12078899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age.
    Abrahamsen JF; Andersen A; Hannisdal E; Nome O; Abrahamsen AF; Kvaløy S; Høst H
    J Clin Oncol; 1993 Feb; 11(2):255-61. PubMed ID: 8426202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sister chromatid exchange studies for monitoring DNA damage in lymphocytes of malignant lymphoma patients under cytostatic therapy.
    Sardaş S; Erdoğan F; Sardaş OS; Cengel M; Karakaya AE
    Anticancer Drugs; 1994 Aug; 5(4):487-9. PubMed ID: 7524801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of Hodgkin's disease and cutaneous B-cell lymphoma in the same patient: a report of two cases.
    Servitje O; Martí RM; Estrach T; Palou J; Gallardo F; Limón A; Romagosa V
    Eur J Dermatol; 2000; 10(1):43-6. PubMed ID: 10694298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
    Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
    Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study.
    Swerdlow AJ; Higgins CD; Smith P; Cunningham D; Hancock BW; Horwich A; Hoskin PJ; Lister TA; Radford JA; Rohatiner AZ; Linch DC
    J Clin Oncol; 2011 Nov; 29(31):4096-104. PubMed ID: 21969511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular replication kinetics and persistence of sister chromatid exchange-inducing lesions in normal and lymphoma AKR cells following exposure to 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Biegel JA; Conner MK; Boggs SS
    Cancer Res; 1982 Jul; 42(7):2816-20. PubMed ID: 7083172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress towards understanding the nature of chromatid breakage.
    Bryant PE; Gray LJ; Peresse N
    Cytogenet Genome Res; 2004; 104(1-4):65-71. PubMed ID: 15162016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sister chromatid exchange assessment by chromosome orientation-fluorescence in situ hybridization on the bovine sex chromosomes and autosomes 16 and 26.
    Revay T; King WA
    Cytogenet Genome Res; 2012; 136(2):107-16. PubMed ID: 22286126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.
    Behrens C; Travis LB; Wistuba II; Davis S; Maitra A; Clarke EA; Lynch CF; Glimelius B; Wiklund T; Tarone R; Gazdar AF
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1027-35. PubMed ID: 11045784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.